Product correctly added to cart.

Ivacaftor

CAS 873054-44-5: Ivacaftor

Description:Ivacaftor is a pharmaceutical compound primarily used in the treatment of cystic fibrosis, particularly in patients with specific mutations in the CFTR gene. It functions as a CFTR potentiator, enhancing the function of the defective protein produced by the CFTR gene. Ivacaftor is characterized by its molecular formula, which includes carbon, hydrogen, nitrogen, and oxygen atoms, contributing to its complex structure. The substance is typically administered orally and is known for its relatively high bioavailability. It exhibits a moderate solubility in water and is often formulated in tablet form for ease of use. Ivacaftor's mechanism of action involves binding to the CFTR protein, facilitating the opening of the chloride channels, which helps to improve ion transport and mucus clearance in the lungs. The drug has been shown to significantly improve lung function and reduce pulmonary exacerbations in patients with the appropriate genetic profile. As with any medication, it is essential to monitor for potential side effects and drug interactions during treatment.

Formula:C24H28N2O3

InChI:InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)

InChI key:InChIKey=PURKAOJPTOLRMP-UHFFFAOYSA-N

SMILES:O=C(NC1=CC(O)=C(C=C1C(C)(C)C)C(C)(C)C)C2=CNC=3C=CC=CC3C2=O

  • Synonyms:
  • 3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-
  • Ivacaftor
  • Kalydeco
  • N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
  • N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
  • N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
  • N-[2,4-Di(tert-butyl)-5-hydroxyphenyl]-4-oxo-1H,4H-quinoline-3-carboxamide
  • Vx-770
Sort by


See more categories

This search does not contain any category.

Found 10 products.

discount label

N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide

CAS:873054-44-5

Ref: IN-DA00399F

1g208.00 €
5g687.00 €
10gTo inquire
25gTo inquire
5mg39.00 €
6kg29,251.00 €
10mg56.00 €
100mg69.00 €
250mg104.00 €
Estimated delivery in United States, on Tuesday 29 Apr 2025
discount label

Ref: 54-OR1027495

1g177.00 €
5g546.00 €
25g2,374.00 €
100mg43.00 €
250mg74.00 €
Estimated delivery in United States, on Monday 28 Apr 2025
discount label

Ivacaftor

CAS:873054-44-5

Ref: 7W-GX4265

250mg152.00 €
Estimated delivery in United States, on Monday 28 Apr 2025
discount label

Ivacaftor

CAS:873054-44-5

Ref: 54-BUP12294

1g1,639.00 €
25mg318.00 €
50mg461.00 €
100mg679.00 €
500mg1,350.00 €
Estimated delivery in United States, on Monday 28 Apr 2025
discount label

Ivacaftor

CAS:873054-44-5

Ref: 4Z-I-056001

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Monday 28 Apr 2025
discount label

Ivacaftor

Controlled Product
CAS:873054-44-5

Ref: 86-MM3921.00-0250

250mg1,270.00 €
Estimated delivery in United States, on Wednesday 30 Apr 2025
discount label

Ivacaftor

CAS:873054-44-5

Ref: TM-T2588

1mg38.00 €
5mg81.00 €
10mg127.00 €
25mg205.00 €
50mg304.00 €
100mg455.00 €
500mg998.00 €
1mL*10mM (DMSO)88.00 €
Estimated delivery in United States, on Tuesday 6 May 2025
discount label

Ivacaftor

CAS:873054-44-5

Ref: TR-I940600

5g2,171.00 €
100mg95.00 €
500mg368.00 €
Estimated delivery in United States, on Wednesday 7 May 2025
discount label

IVACAFTOR

CAS:873054-44-5

Ref: 10-F468426

1g784.00 €
250mgTo inquire
Estimated delivery in United States, on Wednesday 7 May 2025
discount label

Ivacaftor

CAS:873054-44-5

Ref: 3D-FI143182

25mg147.00 €
50mg170.00 €
100mg228.00 €
250mg343.00 €
500mg495.00 €
Estimated delivery in United States, on Thursday 8 May 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".